NEW YORK (GenomeWeb News) – DxS and Exosome Diagnostics said today that they will collaborate on developing blood-based companion diagnostics for cancer gene mutations, such as KRAS, BRAF, and EGFR.

Under the collaboration, the firms will team DxS' Scorpions real-time PCR Mutation Test Kits with Exosome's xOS technology for harvesting nucleic acids from blood exosomes. The firms hope to develop test kits that will measure gene mutations in blood and predict patient response to targeted therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.